This is a permanent results page for your analyzed data. Please save the link in your browser's address bar.
| Title / Description | Chronic myelogenous leukemia response to imatinib: Philadelphia chromosome positive CD34+ cells |
| Accession | GDS3518 |
| Summary | Analysis of Philadelphia chromosome-positive CD34+ cells of chronic myelogenous leukemia patients treated with imatinib. The anti-cancer drug imatinib is a selective bcr-abl tyrosine kinase inhibitor. Results provide insight into the molecular events affected by bcr-abl inhibition through imatinib. |
| Organism | Homo sapiens |
| Platform | GPL571 |
| Normalized | False |
| Parsed SOFT file |
| Differential expression method | Characteristic Direction |
| Cutoff | 500 |
| Cell | CD34+ cells (Philadelphia positive) |
| Perturbation | Imatinib |
| Disease | CML |
| Gene lists | Enrichr | L1000CDS2 | PAEA | |
| Up |
|
|||
| Down |
|
|||
| Combined |
|
|
|
